Tag: The Insider

The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**

The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**

(ASX: CAF) Centrepoint Alliance Limited – John Shuttleworth (ASX: SP3) Spectur Limited – Dr Gerard Dyson

(ASX: PHL) Propell Holdings Limited – Michael Davidson (ASX: LPE) Locality Planning Energy Holdings – Justin Pettett

The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**

(ASX: KIL) Kiland Limited – James Davies (ASX: PVE) Po Valley Energy Limited – Kevin Bailey

The Insider sessions are a great way to hear directly from leading fund managers. They share their approach to investing, favourite companies and their market view for the year ahead.**

(ASX: EVS) Envirosuite Limited – Jason Cooper (ASX: EMD) Emyria Limited – Dr Michael Winlo (ASX: MZZ) Matador Mining Limited – Sam Pazuki

With the price of gold driven by a variety of variables – many outside of the usual supply and demand factors involved in commodity analysis – inflation, interest rates, geopolitical risk and macroeconomic uncertainty are all currently playing a strong role in determining prices. In this The Insider: Investing in Gold Summit, hosted by Reach Markets MD Patrick Nelson, we have industry insiders and experts sharing first-hand insights on the global gold industry, how they think investors are viewing the commodity and their views on how gold is going to fit into the market over an uncertain 2023.

(ASX: PTX) Prescient Therapeutics Limited – Steven Yatomi-Clarke (ASX: EBR) EBR Systems Inc – John McCutheon

(ASX: CCR) Credit Clear Limited – Andrew Smith (ASX: RAC) Race Oncology Limited – Daniel Tillett

Medicinal cannabis is gaining traction among patients and practitioners as a viable form of treatment for a range of conditions. The TGA’s decision to greenlight the sale of medicinal cannabis products over the counter in pharmacies could potentially cause the market to boom, thus sparking investor interest. In this two-part The Insider: Future of Medicinal Cannabis Summit, hosted by Reach Markets MD Patrick Nelson, we have industry insiders and experts sharing first-hand insights on Australia’s emerging medicinal cannabis industry, how investors can take advantage of the opportunities it brings and some of the companies positioned to be top performers.